Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

danazol

A synthetic androgen derived from ethinyl testosterone. Danazol indirectly reduces estrogen production by decreasing pituitary secretion of follicle-stimulating hormone and luteinizing hormone, and binds to sex hormone receptors in target tissues, thereby exhibiting antiestrogenic, anabolic and weakly androgenic effects.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Danocrine
Winobanin
Foreign brand name:Bonzol
Chronogyn
Cyclomen
Danol
Danoval
Ladogal
Abbreviation:DAN
Code name:Win-17757
Chemical structure:(17alpha)-pregna-2,4-dien-20-yno[2,3-d]-isoxazol-17-ol
1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopental[7,8]phenanthro[3,2-d]isoxazol-1-ol
17alpha-ethynyl-17beta-hydroxy-4-androsteno[2,3-d]isoxazole
NSC code:270916
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search